215 related articles for article (PubMed ID: 23588948)
1. Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.
Yang J; Liu P; Tian M; Li Y; Chen W; Li X
Int J Oncol; 2013 Jun; 42(6):2078-86. PubMed ID: 23588948
[TBL] [Abstract][Full Text] [Related]
2. [Preliminary analysis of differentially expressed proteins of clear-cell renal cell carcinoma by comparative proteomic technologies].
Yang J; Li X; Tian MJ; Wang LN; Cheng TT; Chen W
Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):571-6. PubMed ID: 23158988
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
Du P; Ye L; Yang Y; Jiang WG
Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
[TBL] [Abstract][Full Text] [Related]
6. ΑB-crystallin in clear cell renal cell carcinoma: tumor progression and prognostic significance.
Ho PY; Chueh SC; Chiou SH; Wang SM; Lin WC; Lee IL; Yang HY; Peng HC; Lai MK
Urol Oncol; 2013 Oct; 31(7):1367-77. PubMed ID: 22417627
[TBL] [Abstract][Full Text] [Related]
7. Proteomics identified nuclear N-myc downstream-regulated gene 1 as a prognostic tissue biomarker candidate in renal cell carcinoma.
Hosoya N; Sakumoto M; Nakamura Y; Narisawa T; Bilim V; Motoyama T; Tomita Y; Kondo T
Biochim Biophys Acta; 2013 Dec; 1834(12):2630-9. PubMed ID: 23999030
[TBL] [Abstract][Full Text] [Related]
8. High-expression of ZBP-89 correlates with distal metastasis and poor prognosis of patients in clear cell renal cell carcinoma.
Cai MY; Luo RZ; Li YH; Dong P; Zhang ZL; Zhou FJ; Chen JW; Yun JP; Zhang CZ; Cao Y
Biochem Biophys Res Commun; 2012 Oct; 426(4):636-42. PubMed ID: 22982674
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma.
Xue S; Li QW; Che JP; Guo Y; Yang FQ; Zheng JH
Int J Clin Exp Pathol; 2015; 8(4):3765-74. PubMed ID: 26097558
[TBL] [Abstract][Full Text] [Related]
10. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
11. Comparative proteomic profiling identifies potential prognostic factors for human clear cell renal cell carcinoma.
Sun X; Zhang H; Luo L; Zhong K; Ma Y; Fan L; Fu D; Wan L
Oncol Rep; 2016 Dec; 36(6):3131-3138. PubMed ID: 27748938
[TBL] [Abstract][Full Text] [Related]
12. Angiomotin promotes renal epithelial and carcinoma cell proliferation by retaining the nuclear YAP.
Lv M; Li S; Luo C; Zhang X; Shen Y; Sui YX; Wang F; Wang X; Yang J; Liu P; Yang J
Oncotarget; 2016 Mar; 7(11):12393-403. PubMed ID: 26848622
[TBL] [Abstract][Full Text] [Related]
13. [The expression and clinical significance of Annexin II in clear-cell renal cell carcinoma].
Yang J; Cheng TT; Wang LN; Chen W; Li X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jan; 28(1):59-62. PubMed ID: 22230505
[TBL] [Abstract][Full Text] [Related]
14. Identification of cyclophilin A as a potential prognostic factor for clear-cell renal cell carcinoma by comparative proteomic analysis.
Yang J; Li A; Yang Y; Li X
Cancer Biol Ther; 2011 Mar; 11(5):535-46. PubMed ID: 21368578
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of human leukocyte antigen class I (HLA-I) is associated with poor prognosis in patients with clear cell renal cell carcinoma.
Yuan J; Liu S; Yu Q; Lin Y; Bi Y; Wang Y; An R
Acta Histochem; 2013 Jun; 115(5):470-4. PubMed ID: 23245688
[TBL] [Abstract][Full Text] [Related]
16. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
Kosari F; Parker AS; Kube DM; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Vasmatzis G
Clin Cancer Res; 2005 Jul; 11(14):5128-39. PubMed ID: 16033827
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T
J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778
[TBL] [Abstract][Full Text] [Related]
18. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of TGFBI as a promising prognosis marker of clear cell renal cell carcinoma.
Lebdai S; Verhoest G; Parikh H; Jacquet SF; Bensalah K; Chautard D; Rioux Leclercq N; Azzouzi AR; Bigot P
Urol Oncol; 2015 Feb; 33(2):69.e11-8. PubMed ID: 25035170
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]